Olympus unveils newest endoscopic system ever

United Arab Emirates - Olympus Corporation today announced the launch of evis X1, the most advanced endoscopic system ever.

EVIS X1 supports theability to conduct accurate examinations and diagnose diseases accurately and efficiently by providing new and easy-to-use techniques for detecting, diagnosing and treating digestive disorders such as colorectal cancer (CRC)CRCor bronchial diseases. The new technology includes both extended depth field depth(EDOF),red dicolor imaging(RDI)and enhanced color imaging(TXI)as well as proven optical spectrum imaging (NBI)technology.) 

Frank Dwalowski, Head of Endoscopy Solutions  at Olympus Corporation, said: "Evis X1 is olympus's latest EVIS X1 innovation, building on its long and long history of innovation and quality over a century."  

A single binocular system that offers a pioneering mix of knowledge, experience and innovation

Key features of EVIS X1 include:

• Extended Depth field(EDOF):EDOFintegratestwo images with two different focal lengths into one image that provides greater scope for diagnosis and therapeutic decision-making. At the same time,dual Focus provides a dualfocusfunction with two focus in the image and focus onthem simultaneously where they can be activated at the touch of a button.

The Infrared imaging(RDI)is a serious and extremely difficult challenge, with high mortality rates and high administrative costs.RDIThis techniqueuses green, berry and red wavelengths to provide a clear picture of deep blood vessels.

The Enhanced body and color imaging(TXI):TXItechnology providesbetter visibility of infected tissues (e.g. inflammatory areas, flat tissues, and smothered, which are difficult to see with old techniques or even tiny infected tissues) by improving structure, brightness and color to clearly identify the subtle differences of tissues. Thanks to the advanced imaging technology underlying this technology, enhanced imaging technology for structure and color has the potential to make a qualitative shift at the endoscopic level. By providing a clearer view of potential and existing lesions, this innovative technology enhances detection rates and improves quality diagnostic levels.

• Optical Spectrum Imaging(NBI):NBIisa well-known and proven visual technique that allows for visual diagnosis at high levels of confidence by causing high contrast between blood vessels and the surrounding mucosa.

Ready to face future challenges

Olympus is adding new technologies in the near future to EVIS X1,based on Artificial Intelligence technologies, which include introducing new and innovative methods to integrate revolutionary innovations in deep learning into the world of disease detection, diagnosis, phase-out and treatment based on medical imaging.

In addition to the new features offered by the system, EVIS X1 offers new compatibility capabilities between two previously considered separate systems: EVIS LUCERA ELITE and EVIS EXERA III.

Focus on the prevention of colorectal cancer

EVIS X1 can play a pivotal role in preventingcolorectal cancer, particularly through its significant assistance in facilitating screening and early screening of colon icing (benign colon tumors) where the nucleus of the mutation of malignant colon tumors is considered. ^[1] Theglobal burden of colorectal cancer is also expected to increase significantly by 2030. [2] For each 1% increase inthe detection rate of benign tumors(ADR),there is a 3% reduction in the risk of colorectal cancer. ^[3]

M. Kaminsky, Professor at the National Institute of Oncology Research in Warsaw, said: "Early detection and diagnosis is critical in the prevention of colorectal cancer, and EVIS X1 is an easy-to-use system that gives endoscopists a wide range of innovative and effective tools to implement micro-interventional procedures, enabling specialists to "Amongthe new technologies used by the system,TXIlookstruly promising, providing more information to endoscopists while maintaining a close-up of white light endoscopic technology." This technology is easy to adopt."

A new emphasis on global leadership in the field of endoscopy

EVIS X1 is not limited tohealthcare, hospital management and patients around the world, as it is also part of Olympus' implementation of its strategy. "Our goal is to make people's lives healthier and safer," said Takaharu Yamada, Vice President, Global Endoscopy, Olympus Corporation.

EVIS X1 will be launched in The Europe, Middle East, Africa, Australia, India and Hong Kong.

Ihab Yousef
Team Assistant
FleishmanHillard
M +971-545869833
And: ihab.yousef@fleishman.com
http://fleishmanhillard.me/

Middle East Consultancy of the Year 2017 | EMEA SABRE Awards, The Holmes Report
Large Agency of the Year, 2018 | PRWeek Awards
Best Place to Work (Silver), 2018 | PRWeek Best Places to Work Awards
Top Companies for Women, 2010-2018 | National Association for Female Executives
EMEA Network of the Year, 2017 | ICCO Global Awards